The Phase 3 clinical trial results of the Covid-19 vaccine of Johnson & Johnson are expected this month. NeCEN played a role in the underlying research that led to the development of this vaccine. The scientific findings have now been published in Nature Communications.
Please note that NeCEN will be closed 24 December 2020 to 4 January 2021.
During that time, there may be no-one available to respond to queries but you can still submit proposals and we'll get back to you upon our return.
We wish you all Happy Holidays!
Instruct-ERIC is an initiative offering the possibility of free access to Sample Preparation for structural biology studies, Biomolecular Analysis and actual 3D Structural Analysis in facilities in nine European countries. NeCEN is one of the facilities in the Netherlands that is accessible via Instruct-ERIC.
The third webinar in the Instruct-ERIC series 'Structure meets function' will take place on 13 October 2020 at 11:00-12:30 CEST. It is now possible to register.
On 28 July it was announced that Ariane Briegel, Professor of Ultrastructural biology and NeCEN co-director, will receive a 800,000 euro grant from the Gordon and Betty Moore Foundation.
On 6 August 2020 Science published an article on the coronavirus replication organelle. Research was conducted by the Leiden University Medical Center in collaboration with the University of California San Francisco, Leibnitz Institute of Experimental Virology and the University of Hamburg. The EM tomography data of MHV-infected samples were collected at NeCEN.
After technical maintenance and upgrading, both our Titan Krios miscroscopes are now fully operational. Krios 1 has been fitted with a Gatan K3 bioquantum detector. Krios 2 has been fitted with a Gatan K2 bioquantum detector (and still has Falcon3 detector available).
On July 10 a preprint was released on stabilizing the trimeric spike protein of Sars-CoV-2. This protein constitutes the main focus of most vaccine development efforts. The research for this article was a collaboration between Janssen Vaccines & Prevention BV and NeCEN.